Welcome to our dedicated page for Trinity Capital news (Ticker: TRIN), a resource for investors and traders seeking the latest updates and insights on Trinity Capital stock.
Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative asset manager focused on private credit, with a portfolio built around secured loans, equipment financings, and related investments in growth-oriented companies. The TRIN news feed on Stock Titan aggregates company-issued press releases, portfolio updates, and financial announcements that reflect how this strategy is being executed over time.
News coverage for Trinity Capital frequently includes quarterly and annual financial results, portfolio activity summaries, and details on new credit facilities or capital markets transactions. For example, the company issues updates on total investment income, net investment income, net asset value, and the composition and risk ratings of its investment portfolio. It also reports on changes to its borrowing arrangements, such as new or expanded credit facilities and term loan agreements with institutional lenders.
Another major component of TRIN news involves transaction announcements with portfolio companies. Trinity Capital regularly discloses commitments of growth capital and equipment financing to businesses in sectors such as life sciences, technology, financial technology, recycling and materials, and consumer products. These releases describe the purpose of the financing and how it supports the counterparties’ expansion, commercialization, or operational scaling plans, while illustrating the application of Trinity Capital’s lending verticals, including Tech Lending, Life Sciences, Asset Based Lending, and Equipment Finance.
Dividend declarations and distribution policies are also recurring topics. Trinity Capital provides information on regular cash dividends, changes in payment frequency, and its intention to distribute a high percentage of taxable income to maintain regulated investment company status. Investors and analysts can use the TRIN news page to follow these developments, track origination and funding volumes, and review management’s commentary on portfolio performance and market opportunities.
Trinity Capital (TRIN) reported strong Q4 and full-year 2024 results, marking significant growth across key metrics. Q4 highlights include total investment income of $70.8 million (up 48.1% YoY), record net investment income of $34.6 million ($0.58 per share), and a 17.4% Return on Average Equity.
The company achieved total gross investments of $297.3 million in Q4, including $233.4 million in 9 new portfolio companies. Full-year 2024 performance showed total investment income of $237.7 million (30.7% YoY increase) and net investment income of $115.8 million ($2.20 per share). Platform assets under management grew 40.6% to $2.0 billion.
The investment portfolio's fair value reached $1.73 billion, comprising 76.5% first-lien loans. The company maintained strong liquidity with $496.6 million available and expanded its KeyBank Credit Facility to $600 million.
Trinity Capital (NASDAQ: TRIN) has committed $15 million in growth capital to Cagent Vascular, a medical device company specializing in serration technology for vessel dilation in endovascular interventions. This funding complements a $45 million equity financing round led by US Venture Partners in 2024.
Cagent Vascular's flagship product, Serranator®, enhances angioplasty procedures by providing more controlled lumen gain with minimal dissection while reducing vessel recoil. The technology has been utilized in over 20,000 procedures and will use the new funding to scale commercial infrastructure and accelerate clinical adoption.
Trinity Capital (Nasdaq: TRIN) has released preliminary financial estimates for Q4 and full-year 2024. The company expects Q4 2024 net investment income between $0.58 to $0.60 per share, with net asset value per share estimated between $13.32 to $13.37 as of December 31, 2024.
The alternative asset manager reports investment assets at fair value of approximately $1.7 billion. The company's non-accrual investments represented about 0.8% of the total debt investment portfolio at fair value and 2.6% at cost as of year-end 2024.
Trinity Capital (NASDAQ: TRIN) has announced a $25 million growth capital commitment to Wisetack, a pay-over-time platform specializing in home services financing. Wisetack's platform integrates with existing home service business software, enabling services like HVAC, plumbing, and pest control providers to offer flexible payment options to their customers.
The capital will be used to scale Wisetack's operations and fund growth initiatives. Ryan Thompson, Managing Director of Tech Lending at Trinity Capital, highlighted Wisetack's exceptional growth trajectory, customer experience, and strong market position as key factors in the investment decision. Wisetack's founder and CEO, Bobby Tzekin, emphasized that the partnership will help accelerate their growth and innovation in the home services market.
Trinity Capital Inc. (Nasdaq: TRIN) has received confirmation of its investment grade credit rating of 'BBB (low)' with a stable outlook from Morningstar DBRS. This confirmation was announced by Trinity, a leading alternative asset manager. Morningstar DBRS, which rates over 4,000 issuers and 60,000 securities globally, is recognized as the fourth-largest credit rating agency worldwide and maintains a leading position in Canada, the United States, and Europe across multiple asset classes.
Trinity Capital (NASDAQ: TRIN) has committed $30 million in growth capital to Elucent Medical, a medical technology company specializing in guided surgical technologies. Elucent's flagship product, the EnVisio® System, utilizes In-Body Spatial Intelligence™ to provide physicians with 3D surgical awareness through spatial field generation and SmartClip® markers.
The investment follows Elucent's $44 million Series C funding round earlier in 2024. The new capital will support scaling operations and advancing commercialization efforts. The EnVisio® System transforms standard instruments into smart tools, enabling precise soft-tissue surgical excision through continuous 3D positioning data.
Trinity Capital Inc. (TRIN) has announced its earnings release schedule and conference call details for 2025. The company will release quarterly earnings before market opens, followed by conference calls at 12:00 p.m. ET on the following dates: February 26 (Q4/FY 2024), May 7 (Q1 2025), August 6 (Q2 2025), and November 5 (Q3 2025).
For the Q4/FY 2024 call, investors can dial (800) 267-6316 or (203) 518-9783 internationally, using Conference ID: TRINQ424. A replay will be available until March 5, 2025, accessible at (800) 723-0389 or (402) 220-2647. A live webcast will be available on the company's investor relations website, with the replay accessible for 90 days.
Trinity Capital (NASDAQ: TRIN) has announced a significant milestone: its equipment finance vertical has exceeded $1 billion in fundings to high-growth companies since 2018. The achievement highlights the company's role in supporting business growth across various sectors, including manufacturing & automation, energy, space technology, climate tech, and artificial intelligence.
The company has established itself as a key player in capital expenditure financing, supporting notable companies like Hermeus Corp., DrinkPAK, Hadrian Automation, Rocket Lab USA, and Dandelion Energy. This financing solution enables companies to access capital without equity dilution, strengthening their capital structure.
The cited fundings include debt investments made through Trinity Capital's predecessor funds (launched in 2008) until January 16, 2020, when these funds merged with Trinity Capital as it began operating as a business development company.
Trinity Capital (NASDAQ: TRIN) has announced a $30 million growth capital commitment to Silk Technologies, a software-defined cloud storage provider. Silk's platform specializes in enhancing cloud applications and databases performance while optimizing cloud resource usage and data management costs.
The company has demonstrated significant growth, doubling its revenue over the past two years through new customer acquisitions. The funding will support Silk's operational scaling and growth initiatives, particularly as AI drives increased demand for data processing capabilities. The company's solutions target various sectors including finance, healthcare, insurance, and retail industries.
Trinity Capital (NASDAQ: TRIN) has committed $12.5 million in growth capital to Upward Health, an in-home healthcare provider specializing in 24/7 whole-person care for high-risk patients. The funding is part of a larger debt financing package that includes an additional $7.5 million from Comerica Bank, alongside a Series C fundraise led by Heritage Group and Blue Venture Fund.
Upward Health, ranked 7th on the 2023 Inc. 5000 list and 6th in 2024 among fastest-growing private U.S. companies, will use the capital to fund growth initiatives, expand coverage area, and refine their care model. The company partners with health plans and risk-bearing entities to improve health outcomes and quality of life for high-need patients.
FAQ
What is the current stock price of Trinity Capital (TRIN)?
What is the market cap of Trinity Capital (TRIN)?
